Malaria Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others), By Drug Formulation (Tablets, Capsules, Injectables, Others), By End User (Adults, Children, Pregnant Women, Others), By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies) By
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationMalaria Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Drug Type (Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, Others), By Drug Formulation (Tablets, Capsules, Injectables, Others), By End User (Adults, Children, Pregnant Women, Others), By Distribution Channel (Retail pharmacies, Hospitals, Online pharmacies) By
According to the World Health Organization (WHO), in 2020, there were an estimated 229 million cases of malaria globally, with an estimated 409,000 deaths.
Malaria is a potentially life-threatening disease caused by parasites transmitted to humans through the bites of infected female mosquitoes. The parasites responsible for malaria are of the Plasmodium species, with Plasmodium falciparum being the most deadly. Malaria is prevalent in tropical and subtropical regions, particularly in sub-Saharan Africa, where it is a leading cause of morbidity and mortality. Treatment for malaria involves the use of antimalarial medications, which can vary depending on the type and severity of the infection. It is important to seek prompt medical attention if you suspect you have contracted malaria. Malaria is a serious disease and can be fatal if not treated promptly and appropriately.
Malaria therapeutics have a significant impact on patients who are infected with malaria. Malaria therapeutics help to alleviate the symptoms of the disease and prevent it from progressing to severe disease. Effective treatment can reduce the duration and severity of the illness, and prevent complications and long-term health problems. In addition to their direct impact on patients, malaria therapeutics also have broader impacts on public health and society, thereby supporting the growth of global malaria therapeutics market. Effective treatment can reduce the spread of the disease and prevent the development of drug-resistant strains of the parasite. This, in turn, can help to reduce the burden of the disease on healthcare systems and economies.
In 2020, 46 countries reported an increase in malaria cases, with 26 of these countries reporting more than a 20% increase. Children under the age of five are the most vulnerable group affected by malaria, accounting for an estimated 67% of all malaria deaths worldwide in 2020.
Growing incidence of malaria is boosting the Malaria Therapeutics Market
Increased demand for malaria therapeutics as the number of malaria cases increases, there is a greater demand for effective treatments. This presents a significant market opportunity for pharmaceutical companies developing malaria therapeutics.Malaria is a costly disease to treat, both in terms of direct medical expenses and lost productivity. As the incidence of malaria increases, healthcare systems may struggle to keep up with the demand for treatment and prevention, which could lead to increased costs. Malaria can cause severe illness and death, particularly among young children and pregnant women. The growing incidence of malaria means that more people are at risk of contracting the disease, which could lead to increased morbidity and mortality.
Malaria is a significant public health problem in many tropical and subtropical regions of the world, particularly in sub-Saharan Africa, where more than 90% of malaria cases and deaths occur
Therefore, the growing incidence of malaria in several countries is a significant public health challenge that requires a comprehensive and sustained effort to address, thereby supporting the growth of global malaria therapeutics market.
Increasing investment in malaria research is Driving the Demand for Malaria Therapeutics in the Market
Increasing investment in malaria research is driving the demand for malaria therapeutics in the market. Investment in malaria research can lead to the development of new and improved malaria therapeutics, such as drugs and vaccines. These therapeutics can then be marketed and sold to individuals and organizations that are involved in the prevention and treatment of malaria.
In addition to driving demand for malaria therapeutics, increased investment in malaria research can also lead to the creation of new businesses and job opportunities in the pharmaceutical industry. This can have a positive impact on the economy and provide benefits for individuals and communities. Additionally, investment in malaria research is essential to address the global burden of malaria and improve the health outcomes of individuals who are affected by the disease. By driving demand for malaria therapeutics, such investment can play a critical role in achieving these goals.
Investment in malaria research can also lead to increased access to malaria interventions, such as mosquito nets, diagnostic tests, and antimalarial drugs. This can help prevent the spread of the disease and reduce the number of cases and deaths. Investment in malaria research can help strengthen health systems in malaria-endemic countries, leading to improved health outcomes for the population. This can include training healthcare workers, improving healthcare infrastructure, and increasing access to healthcare services.
Malaria disproportionately affects the most vulnerable populations, such as children under five and pregnant women. Increasing investment in malaria research can help reduce health inequities by improving access to prevention and treatment options for these populations.
Investment in malaria research can lead to the development of effective interventions such as vaccines, drugs, and insecticides. These interventions can then be used across multiple countries, leading to a reduction in the burden of malaria in those regions.
Furthermore, Investment in malaria research also lead to increased collaboration between researchers, healthcare providers, and governments across multiple countries. This collaboration can help share best practices and information, leading to better prevention and treatment of malaria across borders.
Additionally, Investment in malaria research can also have an impact on global health security. Malaria is a global health threat, and investing in research can help prevent the spread of the disease across borders and reduce the risk of epidemics.Malaria can cause significant morbidity, leading to long-term health problems in those who survive the disease. Investing in malaria research can help improve health outcomes by reducing the number of cases and the severity of the disease.
Favorable Government initiatives and Policies Drives the Malaria Therapeutics Market Growth
Favorable government initiatives and policies can play a significant role in driving the growth of the malaria therapeutics market. Malaria is a life-threatening disease that affects millions of people globally, particularly in developing countries. To combat the disease, governments across the world have launched various initiatives to promote the development and distribution of malaria therapeutics.
For instance, many governments have allocated significant funds for research and development activities focused on developing effective malaria therapeutics. In addition, governments have also launched programs to increase the accessibility of malaria medications to patients. This includes initiatives aimed at improving the supply chain, reducing the cost of medicines, and increasing awareness among patients.
Another important government initiative is the Roll Back Malaria Partnership
For example, the government of Nigeria launched the National Malaria Elimination Program in 2016, with the goal of reducing the burden of malaria by 2020.
Governments have also implemented policies aimed at promoting the development and distribution of malaria therapeutics. For example, many countries have implemented policies aimed at reducing the cost of malaria medications. In some cases, governments have even provided free or subsidized medications to patients. In addition, many governments have implemented regulatory frameworks aimed at ensuring the quality and safety of malaria therapeutics.
Hence, the support of government initiatives has been crucial in driving the development and distribution of malaria therapeutics. These initiatives have provided funding and support for research and development activities, as well as for programs aimed at improving access to malaria prevention and treatment services. While there is still much work to be done in the fight against malaria, these government initiatives provide hope for a future where malaria is no longer a major public health concern. Hence creating lucrative opportunities for the growth of global malaria therapeutics market in the forecast period.
Recent Developments
Approval of tafenoquineIn 2018, the U.S. Food and Drug Administration (FDA) approved tafenoquine, a new drug for the prevention of relapse of Plasmodium vivax malaria. Tafenoquine is the first new drug to be approved for the prevention of relapse in over 60 years.
New antimalarial drug combinationsIn 2019, a new antimalarial drug combination of lumefantrine and ferroquine was found to be effective against drug-resistant strains of malaria. Another combination, dihydroartemisinin-piperaquine and pyronaridine-artesunate, has also shown promise in clinical trials.
Development of long-acting therapiesSeveral long-acting therapies for the treatment of malaria have been developed in the last three years, including a new injectable formulation of artesunate that can provide protection for up to six months.
Advances in genetic testingAdvances in genetic testing have improved our understanding of the genetics of the malaria parasite, which could lead to the development of more targeted and effective therapies.
Increased use of natural productsThere has been growing interest in the use of natural products for the treatment of malaria, including artemisinin and other plant-based compounds.
Use of digital technologiesDigital technologies, including mobile health platforms, have been used to improve the delivery of malaria treatments and to track the spread of the disease.
New vaccine candidatesSeveral new malaria vaccine candidates have entered clinical trials in the last three years, including a vaccine based on the circumsporozoite protein (CSP) that has shown promising results in early-stage trials.
Download Free Sample Report
Market Segmentation
Global Malaria Therapeutics market
Company Profiles
Novartis AG, Sanofi S.A, Pfizer Inc, GlaxoSmithKline Plc, Merck & Co Inc, F. Hoffmann-La Roche AG, Medicines for Malaria Venture, 60° Pharmaceuticals, Inc, Cipla Limited, Ajanta Pharma Limited are some of the key players of global malaria therapeutics market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | Drug Type Drug Formulations Distribution Channel |
| Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
| Country scope | United States, Mexico, Canada, France, Germany, United Kingdom, Spain, Italy, India, South Korea, Japan, Australia, Vietnam, Indonesia, Myanmar, Brazil, Colombia, South Africa, Saudi Arabia, UAE, Egypt, Turkey, Nigeria |
| Key companies profiled | Novartis AG, Sanofi S.A, Pfizer Inc, GlaxoSmithKline Plc, Merck & Co Inc, F. Hoffmann-La Roche AG, Medicines for Malaria Venture, 60° Pharmaceuticals, Inc, Cipla Limited, Ajanta Pharma Limited. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy